Reviewing Anheuser-Busch InBev SA/NV (NYSE:BUD) and NewAge (NASDAQ:NBEVQ)
Reviewing Anheuser-Busch InBev SA/NV (NYSE:BUD) and NewAge (NASDAQ:NBEVQ)
Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Rating) and NewAge (NASDAQ:NBEVQ – Get Rating) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.
百威英博SA/NV(NYSE:BUD-GET Rating)和新時代(NIO:NBEVQ-GET Rating)都是消費品公司,但哪隻股票更好?我們將根據這兩家公司的分析師建議、盈利能力、機構所有權、風險、股息、估值和收益的強弱對它們進行比較。
Analyst Ratings
分析師評級
This is a breakdown of recent ratings and recommmendations for Anheuser-Busch InBev SA/NV and NewAge, as reported by MarketBeat.
這是MarketBeat報道的安海斯-布希百威英博SA/NV和NewAge最近的評級和推薦細目。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Anheuser-Busch InBev SA/NV | 1 | 2 | 8 | 0 | 2.64 |
NewAge | 0 | 0 | 0 | 0 | N/A |
銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
百威英博SA/NV | 1 | 2 | 8 | 0 | 2.64 |
新時代 | 0 | 0 | 0 | 0 | 不適用 |
Anheuser-Busch InBev SA/NV currently has a consensus price target of $64.70, suggesting a potential upside of 5.91%. Given Anheuser-Busch InBev SA/NV's higher probable upside, analysts plainly believe Anheuser-Busch InBev SA/NV is more favorable than NewAge.
百威英博(Anheuser-Busch InBev SA/NV)目前的共識目標價為64.70美元,暗示潛在上漲5.91%。鑑於百威英博SA/NV的上行可能性更高,分析師顯然認為百威英博SA/NV比NewAge更有利。
Institutional & Insider Ownership
機構與內部人持股
Profitability
盈利能力
This table compares Anheuser-Busch InBev SA/NV and NewAge's net margins, return on equity and return on assets.
此表比較了百威英博SA/NV和NewAge的淨利潤率、股本回報率和資產回報率。
Net Margins | Return on Equity | Return on Assets | |
Anheuser-Busch InBev SA/NV | 8.88% | 15.51% | 5.85% |
NewAge | N/A | N/A | N/A |
淨利潤率 | 股本回報率 | 資產回報率 | |
百威英博SA/NV | 8.88% | 15.51% | 5.85% |
新時代 | 不適用 | 不適用 | 不適用 |
Volatility & Risk
波動性與風險
Anheuser-Busch InBev SA/NV has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, NewAge has a beta of 1.99, suggesting that its share price is 99% more volatile than the S&P 500.
百威英博SA/NV的貝塔係數為1.23,表明其股價的波動性比標準普爾500指數高23%。相比之下,NewAge的貝塔係數為1.99,這表明其股價的波動性比標準普爾500指數高出99%。
Earnings & Valuation
收益與估值
This table compares Anheuser-Busch InBev SA/NV and NewAge's gross revenue, earnings per share and valuation.
此表比較了百威英博SA/NV和NewAge的毛收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Anheuser-Busch InBev SA/NV | $54.30 billion | 2.23 | $4.67 billion | $2.53 | 24.15 |
NewAge | $279.47 million | 0.00 | -$39.34 million | N/A | N/A |
總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
百威英博SA/NV | 543億美元 | 2.23 | 46.7億美元 | $2.53 | 24.15 |
新時代 | 2.7947億美元 | 0.00 | -3,934萬元 | 不適用 | 不適用 |
Anheuser-Busch InBev SA/NV has higher revenue and earnings than NewAge.
安海斯-布希百威英博SA/NV的收入和收益高於NewAge。
Summary
摘要
Anheuser-Busch InBev SA/NV beats NewAge on 10 of the 11 factors compared between the two stocks.
Anheuser-Busch InBev SA/NV在比較兩隻股票的11個因素中有10個超過了NewAge。
About Anheuser-Busch InBev SA/NV
安海斯-布希啤酒公司簡介
(Get Rating)
(獲取評級)
Anheuser-Busch InBev SA/NV engages in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium.
百威英博在全球範圍內從事啤酒、酒精飲料和軟飲料的生產、分銷和銷售。它提供約500個啤酒品牌的投資組合,其中主要包括百威、科羅娜和斯特拉·阿託瓦;貝克、霍加登、萊菲和米歇爾·奧特拉;以及南極洲阿吉拉、百威、巴德萊特、布拉瑪、卡斯、城堡、城堡、水晶、哈爾濱、朱庇勒、Modelo ESpecial、奎爾姆斯、維多利亞、塞德林和斯科爾品牌。該公司成立於1366年,總部設在比利時魯汶。
About NewAge
關於NewAge
(Get Rating)
(獲取評級)
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado. On August 30, 2022, NewAge, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
新時代公司在美國、日本、中國和國際上開發、營銷、銷售和分銷健康產品。該公司分為兩個細分市場,即直銷/社交銷售和直銷商店。它提供健康和保健、能量飲料、精油和抗衰老護膚品、化粧品、飲料、零食、水和空氣過濾、個人護理產品,以及體重管理、營養補充劑、營養食品和瘦身產品;診斷產品,如DNA測試和診斷試劑盒和產品;以及CBD產品。該公司提供的產品有大溪田諾麗、LIMU、Zennoa、LIMU藍蛙、Hiro Natural、Temana、Lucim、Revive、Puritii和MaVie品牌。它直接向客户銷售產品,也可以通過分銷商、電子商務網站和直營店送貨系統銷售。該公司前身為新時代飲料公司,並於2020年7月更名為新時代公司。NewAge,Inc.成立於2010年,總部設在科羅拉多州丹佛市。2022年8月30日,NewAge,Inc.及其附屬公司根據破產法第11章向特拉華州地區美國破產法院提交了自願重組請願書。
Receive News & Ratings for Anheuser-Busch InBev SA/NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anheuser-Busch InBev SA/NV and related companies with MarketBeat.com's FREE daily email newsletter.
獲得Anheuser-Busch InBev SA/NV Daily的新聞和評級-在下面輸入您的電子郵件地址,以通過MarketBeat.com的免費每日電子郵件時事通訊接收對Anheuser-Busch InBev SA/NV和相關公司的最新新聞和分析師評級的每日摘要。
譯文內容由第三人軟體翻譯。